Tomoverse Imaging develops tvCT, an advanced CT imaging platform designed to modernize and streamline planning and execution of complex transcatheter cardiac procedures. The platform was designed by physicians and offers intuitive, high-performance tools with AI-based automation to improve accuracy and efficiency in clinical workflows. The company closed a $5 million Seed funding round to accelerate product development and advance its clinical evidence. Proceeds will be used to complete software development, advance clinical studies, and secure regulatory clearances from the U.S. FDA, Health Canada, and other global bodies. Tomoverse also plans to use the capital to support strategic commercialization efforts in North America and key international markets. The company aims to become the global standard in CT imaging solutions for the rapidly growing structural heart intervention sector.

Total raised

$5M

Funding rounds

1

Latest round

Seed

Latest activity

Jul 2025